GlassScriptPhysician profile
Timothy S Shepherd
NPI 1760488027
$2,924.91
in general payments reported to CMS, 2019-2025
38 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $271 · 2021: $936 · 2022: $538 · 2023: $568 · 2024: $91.14 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $595.28 | 2020-2024 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $469.15 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $358.99 | 2020-2025 | Farxiga, Breztri |
| Pfizer INC. | $155.37 | 2019-2021 | |
| Esperion Therapeutics, INC. | $133.40 | 2020-2021 | |
| Allergan, INC. | $121.05 | 2019-2020 | |
| Lilly USA, LLC | $82.23 | 2022-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $79.18 | 2019-2024 | Veozah |
| Inari Medical, INC. | $67.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $64.42 | 2021-2025 | Proclaim |
| Medtronic, INC. | $63.37 | 2022-2023 | Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $59.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.66 | 2021-2023 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $49.60 | 2022 | |
| Amarin Pharma, INC. | $46.99 | 2019 |
Show all 37 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.